Opening book details…
About this Medicine article
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) by Thiers, B.H. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Thiers, B.H.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0093-3619)
- Published
- 2009
- Field
- Medicine (Health Sciences)